By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial on women diagnosed at an early stage,...
By Julie Steenhuysen (Reuters) -The U.S. Medicare health plan said on Thursday it would limit reimbursement for Eisai Co (OTC:ESAIY) Ltd and Biogen Inc (NASDAQ:BIIB)'s Alzheimer's...
Debt ceiling progress remains elusive with a week to go until the “X-date” when U.S. coffers run dry, but the stock market has a mixed tone this morning thanks to...
(Wednesday market open) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and...
Yesterday dashed hopes that solid mega-cap tech earnings could shake the market out of its funk. Today tests the same proposition following a strong showing late Wednesday from...
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups for service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in over 110 countries.
| Average | 439.50 (-1.07% Downside) |
| High | 507.00 |
| Low | 312.00 |
| Price | 444.26 |
| No. of Analysts | 24 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Sell | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 15.70 | 15.70 | 15.70 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 22.82 | 22.98 | 22.82 | -0.19 | -0.83% | 13.09K | NYSE | |||
| 6.22 | 6.54 | 6.20 | -0.21 | -3.27% | 623.13K | NASDAQ | |||
| 5.00 | 5.00 | 5.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 10.66 | 10.66 | 10.66 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 1,316.00 | 1,349.50 | 1,315.50 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 25.01 | 25.01 | 25.01 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 47.55 | 48.25 | 47.20 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 17.12 | 17.12 | 14.89 | -1.00 | -5.52% | 759.91K | NASDAQ | |||
| 46.85 | 48.70 | 46.60 | -0.48 | -1.01% | 1.08M | NYSE | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 62.03 | 62.89 | 61.42 | -0.27 | -0.43% | 331.73K | NYSE |